Literature DB >> 9744683

An epidemiological study of pityriasis rosea in the Eastern Anatolia.

M Harman1, S Aytekin, S Akdeniz, H S Inalöz.   

Abstract

The purpose of this study was to investigate the epidemiological features of pityriasis rosea (PR) in the Eastern Anatolia, Turkey. Three hundred ninety-one patients (214 females, 177 males) with PR seen during the years 1992-1995 were analyzed for annual incidence among dermatologic outpatients, sex, age, and distribution by month and year. The average annual incidence was 0.75 per 100 dermatologic patients. PR was reported to be slightly more common in women by margin of 1.2:1.0. Eighty-seven percent of the cases were between the ages of 10 and 39 years, with a peak in the 20-29 age group. The incidence of the disease was much higher in the rainy and snowy months. No declining incidence was observed over the years. Changes in incidence from year to year, though not great, were statistically significant.

Entities:  

Mesh:

Year:  1998        PMID: 9744683     DOI: 10.1023/a:1007412330146

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Pityriasis rosea. A statistical, clinical, and laboratory investigation of 826 patients and matched healthy controls.

Authors:  A Björnberg; L Hellgren
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1962

2.  Pityriasis rosea--an autoaggressive disease? Statistical studies in relation to aethiology and pathogenesis.

Authors:  P R Burch; N R Rowell
Journal:  Br J Dermatol       Date:  1970-06       Impact factor: 9.302

3.  Pityriasis rosea in the African.

Authors:  D I Vollum
Journal:  Trans St Johns Hosp Dermatol Soc       Date:  1973

Review 4.  Pityriasis rosea update: 1986.

Authors:  J M Parsons
Journal:  J Am Acad Dermatol       Date:  1986-08       Impact factor: 11.527

5.  Is pityriasis rosea dying?

Authors:  J H Pettit
Journal:  Int J Dermatol       Date:  1983-05       Impact factor: 2.736

6.  An epidemiological study of pityriasis rosea in Middle Road Hospital.

Authors:  W K Cheong; K S Wong
Journal:  Singapore Med J       Date:  1989-02       Impact factor: 1.858

7.  Pityriasis rosea in Lagos.

Authors:  Y Olumide
Journal:  Int J Dermatol       Date:  1987-05       Impact factor: 2.736

8.  Pityriasis rosea in Rochester, Minnesota, 1969 to 1978.

Authors:  T Y Chuang; D M Ilstrup; H O Perry; L T Kurland
Journal:  J Am Acad Dermatol       Date:  1982-07       Impact factor: 11.527

9.  [Pink pityriasis in primary care. Review of 46 cases].

Authors:  M V Castell Alcalá; J Borbujo Martínez; O Olmos Carrasco; M P De Antonio García; R Toribio Dapena; M Casado Jiménez
Journal:  Aten Primaria       Date:  1992-05-15       Impact factor: 1.137

10.  Pityriasis rosea in the Sudan.

Authors:  M A Ahmed
Journal:  Int J Dermatol       Date:  1986-04       Impact factor: 2.736

View more
  4 in total

1.  Interventions for pityriasis rosea.

Authors:  Jose Contreras-Ruiz; Sandra Peternel; Carlos Jiménez Gutiérrez; Ivana Culav-Koscak; Ludovic Reveiz; Maria de Lourdes Silbermann-Reynoso
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

Review 2.  Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies?

Authors:  Antonio Chuh; Vijay Zawar; Gabriel F Sciallis; Werner Kempf; Albert Lee
Journal:  Infect Dis Rep       Date:  2016-03-21

Review 3.  Gianotti-Crosti syndrome, pityriasis rosea, asymmetrical periflexural exanthem, unilateral mediothoracic exanthem, eruptive pseudoangiomatosis, and papular-purpuric gloves and socks syndrome: a brief review and arguments for diagnostic criteria.

Authors:  Antonio Chuh; Vijay Zawar; Michelle Law; Gabriel Sciallis
Journal:  Infect Dis Rep       Date:  2012-02-15

4.  The Oxidant and Antioxidant Status in Pityriasis Rosea.

Authors:  Selma Emre; Gulsen Akoglu; Ahmet Metin; Duriye Deniz Demirseren; Semra Isikoglu; Aynure Oztekin; Ozcan Erel
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.